23 May 2013
Keywords: AstraZeneca, Serroquel XR, Patent validity, USA, Appeals Court
Article | 15 February 2013
AstraZeneca announced that, on 14 February 2013, the US Court of Appeals for the Federal Circuit summarily upheld a lower court ruling ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 February 2013
14 February 2013
© 2013 thepharmaletter.com